Humira biosimilar to see $832 million in sales by 2029: GlobalData
Humira’s 52-week study evaluated adalimumab’s efficacy and safety for moderate-to-severe psoriasis, exploring continuous against…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.